AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Headquarters:
Denmark
Employee Number:
N/A
Technology:
COVID
Industry:
Vaccine/Drug
Number Of Exists:
N/A
Investor Type:
N/A
Founded Date:
N/A
Investment Stage:
N/A
Funding Status:
N/A